Brain natriuretic peptide predicts mortality in the elderly.

T. Wallén, S. Landahl, T. Hedner, K. Nakao, Y. Saito

Department of Geriatric Medicine, Vasa Hospital, University of Gothenburg, Sweden.

OBJECTIVE: To study whether prospective measurements of circulating concentrations of brain natriuretic peptide (BNP) could predict mortality in the general elderly population. DESIGN AND SETTING: Circulating BNP was measured in a cohort of 85 year olds from the general population who were followed up prospectively for five years as part of a longitudinal population study, "70 year old people in Gothenburg, Sweden". PATIENTS: 541 subjects from the 85 year old population in Gothenburg. All subjects were investigated for the presence or absence of cardiovascular disorder such as congestive heart failure, ischaemic heart disease, hypertension, and atrial fibrillation. Venous plasma samples were obtained for BNP analysis. MAIN OUTCOME MEASURE: Overall mortality during the prospective follow up period. RESULTS: Circulating concentrations of BNP predicted five-year mortality in the total population (P < 0.001). In subjects with a known cardiovascular disorder, five-year mortality was correlated with increased BNP concentrations (P < 0.01). Increased BNP concentrations predicted five-year mortality in subjects without a defined cardiovascular disorder (P < 0.05). CONCLUSIONS: In an elderly population, measurements of BNP may add valuable prognostic information and may be used to predict mortality in the total population as well as in patients with known cardiovascular disorders. In subjects without any known cardiovascular disorder, BNP was a strong and independent predictor of total mortality.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Kurl, S, Ala-Kopsala, M, Ruskoaho, H, Makikallio, T, Nyyssonen, K, Vuolteenaho, O, Sivenius, J, Salonen, J T, Laukkanen, J A (2009). Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men. Heart 95: 1067-1071 [Abstract] [Full Text]  
• Frankenstein, L, Clark, A L, Goode, K, Ingle, L, Remppis, A, Schellberg, D, Grabs, F, Nelles, M, Cleland, J G F, Katus, H A, Zugck, C (2009). The prognostic value of individual NT-proBNP values in chronic heart failure does not change with advancing age. Heart 95: 825-829 [Abstract] [Full Text]  
• Whalley, G. A., Wright, S. P., Pearl, A., Gamble, G. D., Walsh, H. J., Richards, M., Doughty, R. N. (2008). Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community. Eur Heart J 29: 509-516 [Abstract] [Full Text]  
• Shadman, R., Allison, M. A., Criqui, M. H. (2007). Glomerular Filtration Rate and N-Terminal Pro-Brain Natriuretic Peptide as Predictors of Cardiovascular Mortality in Vascular Patients. J Am Coll Cardiol 49: 2172-2181 [Abstract] [Full Text]  
• Gan, C. T., McCann, G. P., Marcus, J. T., van Wolferen, S. A., Twisk, J. W., Boonstra, A., Postmus, P. E., Vonk-Noordegraaf, A. (2006). NT-proBNP reflects right ventricular structure and function in pulmonary hypertension. Eur Respir J 28: 1190-1194 [Abstract] [Full Text]  
• Giallauria, F., Lucci, R., De Lorenzo, A., D'Agostino, M., Del Forno, D., Vigorito, C. (2006). Favourable effects of exercise training on N-terminal pro-brain natriuretic peptide plasma levels in elderly patients after acute myocardial infarction. Age Ageing 35: 601-607 [Abstract] [Full Text]  
• Verma, A, Kilicaslan, F, Martin, D O, Minor, S, Starling, R, Marrouche, N F, Almahammed, S, Wazni, O M, Duggal, S, Zuzek, R, Yamaji, H, Cummings, J, Chung, M K, Tchou, P J, Natale, A (2006). Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Heart 92: 190-195 [Abstract] [Full Text]  
• Wright, G A, Struthers, A D (2006). Natriuretic peptides as a prognostic marker and therapeutic target in heart failure. Heart 92: 149-151 [Abstract] [Full Text]  
• Richards, M., Nicholls, M. G., Espiner, E. A., Lainchbury, J. G., Troughton, R. W., Elliott, J., Frampton, C. M., Crozier, I. G., Yandle, T. G., Doughty, R., MacMahon, S., Sharpe, N., for the Christchurch Cardioendocrine Research Grou, , and the Australia-New Zealand Heart Failure Group, (2006). Comparison of B-Type Natriuretic Peptides for Assessment of Cardiac Function and Prognosis in Stable Ischemic Heart Disease. J Am Coll Cardiol 47: 52-60 [Abstract] [Full Text]  
• De Sutter, J., De Bacquer, D., Cuypers, S., Delanghe, J., De Buyzere, M., Kornitzer, M., De Backer, G. (2005). Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study. Eur Heart J 26: 2644-2649 [Abstract] [Full Text]  
• Adlam, D., Silcocks, P., Sparrow, N. (2005). Using BNP to develop a risk score for heart failure in primary care. Eur Heart J 26: 1086-1093 [Abstract] [Full Text]  
• Makikallio, A.M., Makikallio, T.H., Korpelainen, J.T., Vuolteenaho, O., Tapanainen, J.M., Ylitalo, K., Sotaniemi, K.A., Huikuri, H.V., Myllyla, V.V. (2005). Natriuretic Peptides and Mortality After Stroke. Stroke 36: 1016-1020 [Abstract] [Full Text]  
• Kistorp, C., Raymond, I., Pedersen, F., Gustafsson, F., Faber, J., Hildebrandt, P. (2005). N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults. JAMA 293: 1609-1616 [Abstract] [Full Text]  
• Doust, J. A, Pietrzak, E., Dobson, A., Glasziou, P. (2005). How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330: 625- [Abstract] [Full Text]  
• Vanderheyden, M., Goethals, M., Verstreken, S., De Bruyne, B., Muller, K., Van Schuerbeeck, E., Bartunek, J. (2004). Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol 44: 2349-2354 [Abstract] [Full Text]  
• Nielsen, O. W., Kirk, V., Bay, M., Boesgaard, S., Nielsen, H. (2004). Value of N-terminal pro brain natriuretic peptide in the elderly: data from the prospective Copenhagen Hospital Heart Failure study (CHHF). Eur J Heart Fail 6: 275-279 [Abstract] [Full Text]  
• Kirk, V., Bay, M., Parner, J., Krogsgaard, K., Herzog, T.M., Boesgaard, S., Hassager, C., Nielsen, O.W., Aldershvile, J., Nielsen, H. (2004). N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF). Eur J Heart Fail 6: 335-341 [Abstract] [Full Text]  
• Clerico, A., Emdin, M. (2004). Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A Review. Clin. Chem. 50: 33-50 [Abstract] [Full Text]  
• Epshteyn, V., Morrison, K., Krishnaswamy, P., Kazanegra, R., Clopton, P., Mudaliar, S., Edelman, S., Henry, R., Maisel, A. (2003). Utility of B-Type Natriuretic Peptide (BNP) as a Screen for Left Ventricular Dysfunction in Patients With Diabetes. Diabetes Care 26: 2081-2087 [Abstract] [Full Text]  
• Ruskoaho, H. (2003). Cardiac Hormones as Diagnostic Tools in Heart Failure. Endocr. Rev. 24: 341-356 [Abstract] [Full Text]  
• Bay, M, Kirk, V, Parner, J, Hassager, C, Nielsen, H, Krogsgaard, K, Trawinski, J, Boesgaard, S, Aldershvile, J (2003). NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 89: 150-154 [Abstract] [Full Text]  
• Maisel, A. (2002). B-Type Natriuretic Peptide Levels: Diagnostic and Prognostic in Congestive Heart Failure: What's Next?. Circulation 105: 2328-2331 [Full Text]  
• Ferrara, R, Mastrorilli, F, Pasanisi, G, Censi, S, D'aiello, N, Fucili, A, Valgimigli, M, Ferrari, R (2002). Neurohormonal modulation in chronic heart failure. Eur Heart J Suppl 4: D3-D11 [Abstract]  
• Struthers, A D (2002). Introducing a new role for BNP: as a general indicator of cardiac structural disease rather than a specific indicator of systolic dysfunction only. Heart 87: 97-98 [Full Text]  
• Ogawa, E., Saito, Y., Kuwahara, K., Harada, M., Miyamoto, Y., Hamanaka, I., Kajiyama, N., Takahashi, N., Izumi, T., Kawakami, R., Kishimoto, I., Naruse, Y., Mori, N., Nakao, K. (2002). Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression. Cardiovasc Res 53: 451-459 [Abstract] [Full Text]  
• Morrison, L. K., Harrison, A., Krishnaswamy, P., Kazanegra, R., Clopton, P., Maisel, A. (2002). Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39: 202-209 [Abstract] [Full Text]  
• Braunschweig, F., Linde, C., Eriksson, M.J., Hofman-Bang, C., Ryden, L. (2002). Continous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J 23: 59-69 [Abstract] [Full Text]  
• Kalra, P. R, Anker, S. D, Coats, A. J.S (2001). Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin. Cardiovasc Res 51: 495-509 [Full Text]  
• McDonagh, T A, Cunningham, A D, Morrison, C E, McMurray, J J V, Ford, I, Morton, J J, Dargie, H J (2001). Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 86: 21-26 [Abstract] [Full Text]  
• Cheng, V., Kazanagra, R., Garcia, A., Lenert, L., Krishnaswamy, P., Gardetto, N., Clopton, P., Maisel, A. (2001). A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37: 386-391 [Abstract] [Full Text]  
• Cheung, B. M. Y., Kumana, C. R. (1998). Natriuretic Peptides--Relevance in Cardiovascular Disease. JAMA 280: 1983-1984 [Full Text]  
• Bevilacqua, M., Vago, T., Baldi, G., Norbiato, G., Masson, S., Latini, R. (1997). Analytical Agreement and Clinical Correlates of Plasma Brain Natriuretic Peptide Measured by Three Immunoassays in Patients with Heart Failure. Clin. Chem. 43: 2439-2440 [Full Text]